Common anti-epileptic medication shows promise in reducing migraine aura
A new study by researchers at Lund University in Sweden found that 85 percent of patients with aura-dominant migraine experienced a reduction in monthly aura days by at least half following treatment with the anti-epileptic drug lamotrigine.
Read original article on The Medical News →Related news
-
Half of new parents have unwanted, intrusive thoughts of harming their infants. Research suggests most aren't dangerous.
United Kingdom
-
Nike Founder Phil Knight Gives Away a Billion Dollars – the Largest Single Donation to a Public University
United Kingdom
-
Daily oral GLP-1 medication linked to similar weight loss across three menopausal stages
United Kingdom
-
ADHD and autism appear more common among young people diagnosed with type 2 diabetes
United Kingdom
-
Kidney disease, heart failure or death risk climbs to 55% 10 years after type 2 diabetes diagnosis
United Kingdom
-
Reducing ultra-processed foods, being physically active can cut risk of type 2 diabetes, regardless of genetic makeup
United Kingdom
-
Blood test shows whether newborns with fever have bacterial or viral infection
United Kingdom
-
Leg pain can warn of a serious condition: Why peripheral artery disease (PAD) needs more attention
United Kingdom